The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors : An ANNEXA-4 Subanalysis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
|---|---|
| Enthalten in: |
Circulation - 149(2024), 16 vom: 16. Apr., Seite 1315-1318 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Siegal, Deborah M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9NDF7JZ4M3 |
|---|
| Anmerkungen: |
Date Completed 17.04.2024 Date Revised 17.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIRCULATIONAHA.123.066933 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371094208 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371094208 | ||
| 003 | DE-627 | ||
| 005 | 20240417233020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCULATIONAHA.123.066933 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1378.xml |
| 035 | |a (DE-627)NLM371094208 | ||
| 035 | |a (NLM)38620086 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Siegal, Deborah M |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors |b An ANNEXA-4 Subanalysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2024 | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a anticoagulants | |
| 650 | 4 | |a factor Xa | |
| 650 | 4 | |a factor Xa inhibitors | |
| 650 | 4 | |a gastrointestinal hemorrhage | |
| 650 | 4 | |a hemostasis | |
| 650 | 7 | |a Factor Xa Inhibitors |2 NLM | |
| 650 | 7 | |a PRT064445 |2 NLM | |
| 650 | 7 | |a Factor Xa |2 NLM | |
| 650 | 7 | |a EC 3.4.21.6 |2 NLM | |
| 650 | 7 | |a Recombinant Proteins |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Rivaroxaban |2 NLM | |
| 650 | 7 | |a 9NDF7JZ4M3 |2 NLM | |
| 700 | 1 | |a Forbes, Nauzer |e verfasserin |4 aut | |
| 700 | 1 | |a Eikelboom, John |e verfasserin |4 aut | |
| 700 | 1 | |a Beyer-Westendorf, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen, Alexander T |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Lizhen |e verfasserin |4 aut | |
| 700 | 1 | |a Connolly, Stuart J |e verfasserin |4 aut | |
| 700 | 1 | |a Crowther, Mark |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d 1950 |g 149(2024), 16 vom: 16. Apr., Seite 1315-1318 |w (DE-627)NLM000039020 |x 1524-4539 |7 nnns |
| 773 | 1 | 8 | |g volume:149 |g year:2024 |g number:16 |g day:16 |g month:04 |g pages:1315-1318 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCULATIONAHA.123.066933 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 149 |j 2024 |e 16 |b 16 |c 04 |h 1315-1318 | ||